Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Study of Low Back Pain Using CERSR® Imaging Technology

29. juli 2011 oppdatert av: Verium Diagnostics, Inc.

Observational Study of the Electrophysiological Course of Low Back Pain Using CERSR® Imaging Technology

The purpose of this research study is to measure with CERSR® (Computerized Electrophysiological Reconstruction of the Spinal Regions) the electrical signals made by the muscles in the lower back 1) when the subject has no low back pain 2) during the time low back pain begins, or 3) during the treatment and resolution of the low back pain, and 4) to study the changes which take place in these muscles as the pain improves with physical therapy treatment as an intervention. The hypotheses to be tested are 1) The CERSR® scan parameters for normal (pain-free) subjects are different from those of subjects with low back pain. 2) CERSR® scan aids the physician in determining a directed physical therapy treatment which leads to relief of low back pain following no more than eight weeks of physical therapy, as measured by relief of pain using a Visual Analog Scale and symptom improvement as measured using the Oswestry Disability Index.

Studieoversikt

Status

Avsluttet

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The purpose of this research study is to measure with CERSR® (Computerized Electrophysiological Reconstruction of the Spinal Regions) the electrical signals made by the muscles in the lower back 1) when the subject has no low back pain 2) during the time low back pain begins, or 3) during the treatment and resolution of the low back pain, and 4) to study the changes which take place in these muscles as the pain improves with physical therapy treatment as an intervention. The hypotheses to be tested are 1) The CERSR® scan parameters for normal (pain-free) subjects are different from those of subjects with low back pain. 2) CERSR® scan aids the physician in determining a directed physical therapy treatment which leads to relief of low back pain following no more than eight weeks of physical therapy, as measured by relief of pain using a Visual Analog Scale and symptom improvement as measured using the Oswestry Disability Index.

Studietype

Observasjonsmessig

Registrering (Forventet)

290

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • Ohio
      • Akron, Ohio, Forente stater, 44304-1619
        • Summa Center for Clinical Trials
      • Akron, Ohio, Forente stater, 44310-3110
        • Summa St. Thomas Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The subjects will be selected from employees of Summa Health System. Current employees as well as new hires will be eligible to participate in the study.

Beskrivelse

Inclusion Criteria Groups A, B and C:

  1. Male and female employees of the study center.
  2. Between the ages of 18 and 70 years.
  3. Current employees as well as new hires.

Exclusion Criteria Group A:

1. Low back pain.

Exclusion Criteria Group B:

  1. Low back pain due to fracture, tumor, infection, cauda equina, severe neurological deficit.
  2. Pregnant.
  3. Sensitivity to isopropyl alcohol used to prepare the low back surface.
  4. Inability to complete the required collection positions for the CERSR® scan.
  5. Inability or unwillingness to adhere to the protocol and follow-up schedule.
  6. Anyone under care of a physician for active liability or workman compensation cases.
  7. Anyone who has had an open spinal procedure in the last three months.
  8. Anyone who has undergone spine injections within the last two months.

Exclusion Criteria Group C:

  1. Low back pain due to fracture, tumor, infection, cauda equina, severe neurological deficit
  2. Pregnant.
  3. Sensitivity to isopropyl alcohol used to prepare the low back surface.
  4. Inability to complete the required collection positions for the CERSR scan.
  5. Inability or unwillingness to adhere to the protocol and follow-up schedule.
  6. Anyone under care of a physician for active liability or workman compensation cases.
  7. Anyone who has had an open spinal procedure in the last three months.
  8. Anyone who has undergone spine injections within the last two months.
  9. Anyone who is currently undergoing physical therapy or chiropractic treatments.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Group A
Subjects who do not currently have low back pain.
Group B
Subjects who have low back pain at the time of the study, and who are currently being treated or have been previously treated for their low back pain and do not wish to receive further treatment for their pain.
Group C
Subjects who have low back pain at the time of the study, and wish to receive physical therapy to reduce their low back pain.
Annen: Physical Therapy
The physician will complete a physical exam as well as analyze a completed CERSR® scan study to determine the root cause of the low back pain. The physician will then prescribe a targeted physical therapy regime to address the cause of the low back pain.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change from Baseline in Pain Visual Analog Scale
Tidsramme: Upon enrollment (day 1 - baseline) and four weeks and eight weeks
The subjects will complete a form indicating their pain level upon enrollment. Subjects will then be scanned again at four weeks and at eight weeks. At the time of the scan subjects will also be asked to complete a follow up VAS. Upon completion of the study the change in VAS scores will be analyzed.
Upon enrollment (day 1 - baseline) and four weeks and eight weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change from Baseline Oswestry Disability Index (ODI)
Tidsramme: Upon enrollment (day 1 - baseline) and at four weeks and at eight weeks
The subjects will complete the Oswestry Disability Index upon enrollment. Subjects will then be scanned again at four weeks and at eight weeks. At the time of the scan subjects will also be asked to complete a follow up ODI. Upon completion of the study the change in ODI scores will be analyzed.
Upon enrollment (day 1 - baseline) and at four weeks and at eight weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Verium Diagnostics, Inc.

Etterforskere

  • Hovedetterforsker: Nilesh Shah, M.D., Summa Health Systems

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mai 2011

Datoer for studieregistrering

Først innsendt

29. mars 2011

Først innsendt som oppfylte QC-kriteriene

21. juli 2011

Først lagt ut (Anslag)

25. juli 2011

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

1. august 2011

Siste oppdatering sendt inn som oppfylte QC-kriteriene

29. juli 2011

Sist bekreftet

1. juli 2011

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • SMI-2010-002
  • RP# 11002 (Annen identifikator: Summa Health Systems IRB)

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere